Regulatory Document Management Software for Pharma

The Common Technical Document format organises submission content into five modules covering administrative, quality, nonclinical, and clinical data, with each module divided into sections that vary in whether they are mandatory or optional depending on submission type and the agency receiving the filing. A system that does not reflect this hierarchy cannot enforce completeness or surface missing sections before the dossier is assembled. We build document repositories structured around the CTD module and section hierarchy, so every document is stored in its correct position within the submission architecture. Mandatory sections for each submission type are flagged, and optional sections are visible but do not generate completeness warnings unless the regulatory affairs team has marked them in scope. Documents can be linked across modules where cross-references are required, maintaining those links when document versions change. The result is a repository where completeness is a system property, not something a reviewer checks manually against a spreadsheet before each submission.

Every document in a regulatory submission dossier has a history -- drafts, review comments, revisions in response to those comments, and a final approved version. When that history lives in email threads and file naming conventions, it cannot be audited and it cannot be trusted. We build version control into the document repository so every revision creates a new version record with the author, date, change summary, and a diff against the previous version. Approval workflows route documents to the correct reviewers in sequence -- a document requiring sign-off from a regulatory affairs lead and a medical director follows that sequence, with each reviewer receiving notification when it reaches them and the approval chain recorded in the document history. Documents cannot advance to submission-ready status without completing the defined approval sequence. Change tracking is maintained across versions so an agency reviewer asking when a specific text change was made and who approved it gets a precise answer from the system rather than a search through email archives.

FDA, EMA, and PMDA each publish technical submission requirements covering document format, file type, metadata fields, naming conventions, and hyperlink structure. Errors in any of these result in a refusal to file or a validation failure that delays the submission while the regulatory affairs team identifies and corrects the non-conforming documents. Manual format checking across a dossier of several hundred files is an error-prone process that depends on team members remembering the current version of each agency's technical requirements. We build automated format validation that checks documents against the submission template for the target agency before the dossier is assembled. Errors are surfaced at the document level -- which file, which requirement, what the system found versus what is expected -- so the team can resolve issues one by one rather than discovering them as a batch failure at submission time. Validation rules are updated as agency technical requirements change, without requiring manual updates to each submission checklist.

Electronic CTD submissions require more than correctly formatted documents -- they require an XML backbone that describes the structure and relationships of the submission, validated against the agency-specific Document Type Definition and the regional eCTD specification. A dossier that contains well-prepared documents but an invalid backbone will fail the agency's technical validation step and be returned without review. We build eCTD compilation tools that generate the XML backbone from the document repository, applying the correct leaf numbering, section codes, and relationship attributes defined by the target agency's specification. The compiled package is validated against the FDA, EMA, or PMDA DTD before it leaves the system, with validation errors reported against the specific backbone element or document that caused the failure. For life-cycle submissions -- amendments, supplements, and variations -- the system maintains the submission history and generates the incremental eCTD packages that reference the correct prior submissions.

21 CFR Part 11 defines the technical requirements for electronic records and electronic signatures in FDA-regulated environments. The requirements are specific: signatures must be binding to the individual who applied them, must record the date and time of signing, must be linked to the document in a way that makes tampering detectable, and must be subject to controls that prevent unauthorised use of another person's signature credentials. We build electronic signature functionality that satisfies these requirements -- approval actions are bound to the authenticated user identity, timestamped, and written to an audit trail that is stored separately from the document content and cannot be modified after the fact. The audit trail records every action taken on every document in the system: creation, revision, review, approval, and submission. This record is available for regulatory inspection at any time and does not depend on reconstructing events from email logs or file system metadata. Every document's complete history, from first draft to submission, is stored in the system and retrievable in minutes.

A pharmaceutical company filing the same compound with FDA, EMA, and PMDA simultaneously is managing three parallel submission processes with different requirements, different timelines, and different regulatory responses. Tracking submission status across these agencies in spreadsheets creates coordination failures -- a document updated in response to an FDA query is not automatically flagged for review in the EMA dossier, and a PMDA validation failure is discovered days after the filing date because the team monitoring the US submission was not watching the Japanese agency queue. We build multi-market submission tracking that consolidates the status of every active dossier across all target agencies in a single view. Submission milestones, agency validation results, question-and-answer cycles, and approval decisions are tracked per agency with timeline visibility across the full programme. When a document is updated in one market dossier, the system flags whether the same document appears in other active dossiers so the regulatory affairs team can decide whether to apply the same revision across markets or maintain market-specific versions.